We are very pleased to launch an innovative new service to provide wider access to our specialist prostate cancer advice and guidance. Patients are now able to book telephone based advice and guidance with Alan Doherty, founding consultant urologist of the Birmingham Prostate Clinic. This new service may suit men who are seeking a prostate […]
Read more The most significant developments in my field recently have not been in how we treat prostate cancer, but what we do beforehand, to assess and understand the disease. Six years ago, like all UK urologists, the prostate biopsy I commonly used was the TRUS (transrectal ultrasound-guided biopsy). It involves inserting 12 needles through the rectum […]
Read more
By Alan Doherty, consultant urologist and founder of the Birmingham Prostate Clinic The annual meeting of the British Association of Urological Surgeons always provides a valuable bellwether for key developments in prostate cancer. I attended this year’s meeting in Liverpool at the end of June and one theme particularly stood out: the use of MRI […]
Read more
How reliable is the PCA3 test for prostate cancer? What we have learnt from undertaking 688 tests By Alan Doherty Back in 2007, we were one of the first clinics in the UK to introduce a new type of test for prostate cancer. This test was based on the discovery that very high levels of […]
Read more The main question for GPs: raised PSA and prostate cancer By Alan Doherty, consultant urologist, Birmingham Prostate Clinic I am pleased to have another opportunity to meet GPs for an educational event on November 17. I attend these events as often as possible, because we need effective connections between the GP surgery and hospital. Meeting […]
Read more Men with prostate cancer have the best survival chances if they live in Birmingham and the Black Country, a report has shown. The report, by Macmillan Cancer Support, highlights some striking differences in survival, depending upon where patients live. Focusing on prostate cancer, the figures show five year survival at 86.3 per cent in the […]
Read more
James Derbyshire* is one of the first patients to have the state-of-the-art Cyberknife treatment in Birmingham. The intensive and extremely accurate technology reduces the number of sessions from 37 to just five. Mr Derbyshire, who is 72, describes his experience. “My prostate cancer was diagnosed purely by chance and persistence. It started with some slightly […]
Read more Harry Williams* was one of the first men in the UK to be treated outside of London with the CyberKnife procedure for prostate cancer. Mr Williams, aged 77, outlines his experience, explains why he chose CyberKnife and how he got on with the treatment. “After a quite rewarding career in banking and finance I truly […]
Read more
Peter Hale is a 70-year-old from Birmingham. He was referred to the Birmingham Prostate Clinic for assessments after finding blood in his urine. Mr Hale had a series of tests, including the new genetics-based PCA3 assessment. His prostate was found to be benign and Mr Hale is now on active monitoring.
Read more